Glecirasib
7-(2-amino-3,4,5,6-tetrafluorophenyl)-6-chloro-1-(4-methyl-2-propan-2-yl-3-pyridinyl)-2-oxo-4-(4-prop-2-enoylpiperazin-1-yl)-1,8-naphthyridine-3-carbonitrile
Molecular Identity
Glecirasib
7-(2-amino-3,4,5,6-tetrafluorophenyl)-6-chloro-1-(4-methyl-2-propan-2-yl-3-pyridinyl)-2-oxo-4-(4-prop-2-enoylpiperazin-1-yl)-1,8-naphthyridine-3-carbonitrile
PubChem CID: 157827766
2D Structure
Properties
C31H26ClF4N7O2
Molecular Formula
640.00
Molecular Weight
g/mol
639.1773
Exact Mass
Da
4.4
XLogP
Drug-like (Lipinski: < 5)
119
TPSA
Good oral absorption (< 140 A²)
1
H-Bond Donors
11
H-Bond Acceptors
1240
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
GlecirasibUP75WH4QKMRefChem:1085811KRAS G12C inhibitor 362657613-87-9KRAS G12C inhibitor 622658538-04-42658588-10-2glecirasib [INN]orb1944488orb2279110CHEMBL5314518SCHEMBL23830094SCHEMBL29459974EX-A8185Q
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Glecirasib
Loading drug network...